Following the successful filing of Intellectual Property (IP) for their applied platform technology targeting the endocannabinoid system (ECS), Tetra Pharm Technologies, is moving forward with its compound...

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its new analytical platform, LabZient™. 

Rehabtronics, a leading innovator in neurostimulation technologies, is pleased to announce that it has been selected by the Praxis Spinal Cord Institute to conduct a usability and validation study...

Evogene Ltd. a leading computational biology company targeting to revolutionize life-science product development across multiple market segments, and Verb Biotics LLC. A microbiome health ingredient company...

Viscient Biosciences ("Viscient") announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical research institute, and Salk...

CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), today announced the evolution of its loyalty program to include two membership tiers: ExtraCare® and ExtraCare Plus™.

Octapharma USA has announced Balfaxar® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex®) is now available.